HANNAH ALISON L. Insider Trades

Insider Trading History

Track insider trading activity for HANNAH ALISON L.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Medical Officer
Holding Value $1.44M 35,025 shares
Last Trade
Jul 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.05M 24,400 shares
$42.92
$41.18
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $674k 16,375 shares
Last Trade
May 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 5,750 shares
$29.01
$41.18
Neogenomics
Neogenomics NEO
Director
Holding Value $0 0 shares
Last Trade
Jun 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$89.2k 12,254 shares
$7.28
$14.50
Neogenomics
Neogenomics NEO
Director
Holding Value $1.9M 131,023 shares
Last Trade
Jun 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$89.2k 12,254 shares
$7.28
$14.50
Neogenomics
Neogenomics NEO
Director
Holding Value $1.9M 131,023 shares
Last Trade
Jun 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$117k 16,107 shares
$7.28
$14.50
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $438k 10,625 shares
Last Trade
May 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56.9k 3,000 shares
$18.95
$41.18
Neogenomics
Neogenomics NEO
Director
Holding Value $1.72M 118,769 shares
Last Trade
Aug 10, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$188k 11,336 shares
$16.55
$14.50
Neogenomics
Neogenomics NEO
Director
Holding Value $0 0 shares
Last Trade
Aug 10, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$188k 11,336 shares
$16.55
$14.50
Neogenomics
Neogenomics NEO
Director
Holding Value $178k 12,254 shares
Last Trade
Jun 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$119k 8,672 shares
$13.71
$14.50
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $3.35M 81,250 shares
Last Trade
May 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$272k 30,000 shares
$9.07
$41.18
Neogenomics
Neogenomics NEO
Director
Holding Value $164k 11,336 shares
Last Trade
Aug 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$124k 8,353 shares
$14.82
$14.50
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $2.32M 56,250 shares
Last Trade
May 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$396k 30,000 shares
$13.20
$41.18
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Medical Officer
Holding Value $117k 31,898 shares
Last Trade
Jul 19, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.95k 5,602 shares
$1.42
$3.68
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Medical Officer
Holding Value $138k 37,500 shares
Last Trade
Jul 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.5k 15,000 shares
$1.50
$3.68
Neogenomics
Neogenomics NEO
Director
Holding Value $1.56M 107,433 shares
Last Trade
Jun 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 15,556 shares
$7.71
$14.50
Neogenomics
Neogenomics NEO
Director
Holding Value $201k 13,882 shares
Last Trade
Jun 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 13,882 shares
$8.10
$14.50
Neogenomics
Neogenomics NEO
Director
Holding Value $201k 13,882 shares
Last Trade
Jun 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$107k 13,882 shares
$7.71
$14.50
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $1.24M 30,000 shares
Last Trade
May 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$603k 30,000 shares
$20.10
$41.18
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Medical Officer
Holding Value $497k 135,000 shares
Last Trade
Feb 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$558k 135,000 shares
$4.13
$3.68
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Medical Officer
Holding Value $82.8k 22,500 shares
Last Trade
Feb 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$92.9k 22,500 shares
$4.13
$3.68

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up